New drug combo tested to fight tough head and neck cancers
NCT ID NCT02270814
Summary
This study is testing a combination of three cancer drugs (cisplatin, nab-paclitaxel, and cetuximab, called CACTUX) for people with incurable head and neck cancer that has spread or returned. The main goal is to see if this combination can help control the cancer for a longer time without it getting worse, while also tracking side effects and quality of life. It is for adults whose cancer cannot be cured by surgery or radiation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sanford Cancer Center Oncology Clinic and Pharmacy
Sioux Falls, South Dakota, 57104, United States
-
Sanford Roger Maris Cancer Center
Fargo, North Dakota, 58122, United States
-
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
-
University of Mississippi Medical Center
Jackson, Mississippi, 39216, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.